Quantbot Technologies LP Adaptimmune Therapeutics PLC Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$1.73 - $4.06 $3,460 - $8,119	2,000 New	2,000 $4,000
Q4 2018 Feb 13, 2019	SELL	$3.76 - $14.16 $30,215 - $113,789	-8,036 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$8.27 - $13.56 $17,805 - $29,194	-2,153 Reduced 21.13%	8,036 $108,000
Q2 2018 Aug 13, 2018	BUY	$10.42 - $13.74 $106,169 - $139,996	10,189 New	10,189 $120,000

145M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $98M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.